Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Accured Expenses (2020 - 2023)

Terns Pharmaceuticals' Change in Accured Expenses history spans 4 years, with the latest figure at $772000.0 for Q4 2023.

  • For Q4 2023, Change in Accured Expenses fell 42.81% year-over-year to $772000.0; the TTM value through Dec 2023 reached $2.7 million, up 92.73%, while the annual FY2025 figure was $629000.0, 85.18% down from the prior year.
  • Change in Accured Expenses reached $772000.0 in Q4 2023 per TERN's latest filing, up from $6000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q1 2023 to a low of -$3.9 million in Q1 2021.
  • Average Change in Accured Expenses over 4 years is $347375.0, with a median of $398500.0 recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: crashed 700.0% in 2021, then surged 4766.67% in 2022.
  • A 4-year view of Change in Accured Expenses shows it stood at -$77000.0 in 2020, then plummeted by 700.0% to -$616000.0 in 2021, then surged by 319.16% to $1.3 million in 2022, then plummeted by 42.81% to $772000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Change in Accured Expenses are $772000.0 (Q4 2023), $6000.0 (Q3 2023), and -$715000.0 (Q2 2023).